379 results on '"Rebolj, Matejka"'
Search Results
2. Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening
3. Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study
4. The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot
5. Supporting the implementation of new healthcare technologies by investigating generalisability of pilot studies using area-level statistics
6. Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis
7. Cervical screening during the COVID-19 pandemic: optimising recovery strategies
8. Variations in pathways and resource use in follow-up after abnormal mammography screening: a nationwide register-based study
9. Gaps between recommendations and their implementation: A register-based study of follow-up after abnormalities in cervical cancer screening
10. Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
11. Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening
12. Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years
13. 16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
14. Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis
15. Managing an extension of screening intervals: Avoiding boom and bust in health care workloads
16. Widening the offer of human papillomavirus self‐sampling to all women eligible for cervical screening: Make haste slowly.
17. Widening the offer of human papillomavirus self‐sampling to all women eligible for cervical screening: Make haste slowly
18. A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions
19. HPV mRNA testing in cervical cancer screening
20. Mothers' and their daughters' use of preventive measures against cervical cancer
21. Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology
22. Author response: A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions
23. Health impacts of COVID-19 disruptions to primary cervical screening by time since last screen: A model-based analysis for current and future disruptions
24. Outcomes in cervical screening using various cytology technologies : What’s age got to do with it? Erratum
25. Incidence of Genital Warts in Young Danish Women
26. Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data
27. Comments on: “Meta‐analysis of agreement/concordance statistics in studies comparing self‐ vs clinician‐collected samples for HPV testing in cervical cancer screening”
28. COVID-19 disruption to cervical cancer screening in England
29. Outcomes in cervical screening using various cytology technologies : What’s age got to do with it?
30. Additional file 1 of Supporting the implementation of new healthcare technologies by investigating generalisability of pilot studies using area-level statistics
31. sj-docx-1-msc-10.1177_09691413221090892 - Supplemental material for COVID-19 disruption to cervical cancer screening in England
32. Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study
33. Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study
34. Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30 : systematic review
35. Non-participation in screening: The case of cervical cancer in Denmark
36. Register-based studies of cancer screening effects
37. The Danish National Patient Register
38. Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review
39. Reply to ‘Comment on ‘Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis”
40. Incidence of Cervical Cancer after Several Negative Smear Results by Age 50: Prospective Observational Study
41. Long Term Predictive Values of Cytology and Human Papillomavirus Testing in Cervical Cancer Screening: Joint European Cohort Study
42. Adherence to follow‐up after the exit cervical cancer screening test at age 60–64: A nationwide register‐based study
43. Psychological effects of diagnosis and treatment of cervical intraepithelial neoplasia: a systematic review
44. Risk of cervical cancer in women with autoimmune diseases, in relation with their use of immunosuppressants and screening: Population-based cohort study
45. Age‐specific outcomes from the first round of HPV screening in unvaccinated women: Observational study from the English cervical screening pilot.
46. Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilot.
47. Cervical cancer screening at crossroads
48. Mortality of non-participants in cervical screening: Register-based cohort study
49. Acceleration of cervical cancer diagnosis with human papillomavirus testing below age 30: Observational study.
50. Long-term adherence to follow-up after treatment of cervical intraepithelial neoplasia: nationwide population-based study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.